top of page
BD Scouting · Any disease · Global
Emerging researchers,
mapped before they're famous

We scan grants from 100+ global funding bodies, cross-reference publications and modalities, and deliver a precision scouting database — for any disease area, any geography, any MoA. Oncology. Rare disease. CNS. Cardiometabolic. You name it.

01

This is a title. Click here to edit.

02

This is a title. Click here to edit and add your own text.

03

This is a title. Click here to edit and add your own text.

- Veterinary · One Health

Where human and
animal health converge

​

OniX brings the same BD intelligence precision to veterinary innovation. Cross-species therapeutic translation, emerging vet-pharma researchers, and One Health partnership development.

​

Rapid Scan · 2 weeks

Validate a new therapeutic area fast

A focused 2-week deliverable covering one disease area and one funding ecosystem (e.g., NIH or EU). Returns 15–25 researcher profiles with MoA tags, grant details, and a BD brief. Ideal for validating pipeline expansion decisions before committing to a full project.

1 disease · 1-5 funders

Single-focus rapid assessment with 15–25 researcher profiles

  • Researcher profiles: name, title, institution, country, email where available

  • Funding details: grant number, funder, amount, period

  • MoA/modality classification: GT, SM, biologic, peptide, mAb, CRISPR, ASO, cell

  • Recent key publications with BD relevance notes

  • BD brief: strategic read on the landscape and top targets

Deep Global Scout · 2 -4  weeks

  • All Rapid Scan deliverables, expanded to global scope

  • Priority tiering: top 10 BD targets with outreach recommendations

  • Conference calendar: ASBMR, ESHRE, ISDS, ESPE, and disease-specific meetings

  • Warm introduction facilitation to top-tier targets

  • Competitive positioning: who else is scouting this space

The full global picture your competitors don't have

A comprehensive multi-funder, multi-country scan covering 40–60 researcher profiles across NIH, UKRI, DFG, ANR/INSERM, EU Horizon/ERC, Telethon, JSPS/AMED, NHMRC, and more. Includes priority triage and warm introduction facilitation.

Global · 10+ funders

40–60 researchers, 15+ countries, all major funding bodies

Retainer Intelligence · Ongoing

Never miss a new grant, publication, or emerging PI

Continuous monitoring of your priority disease areas. Monthly researcher updates, new grant alerts, publication tracking, conference prep packages, and competitive positioning reports delivered on a regular cadence.

Monthly

New grants, researchers, publications, and landscape shifts

  • Monthly new researcher alerts with BD priority scoring

  • Grant radar: new awards from NIH, EU, and 8+ other agencies

  • Publication digest: key papers relevant to your pipeline

  • Quarterly conference prep: who to meet, what sessions to attend

  • Bi-annual full landscape refresh and competitive update

Disease & therapeutic coverage

  • Oncology: solid tumors, liquid tumors, immuno-oncology, ADC targets, emerging I/O mechanisms

  • Rare & orphan diseases: bone, metabolic, lysosomal storage, neuromuscular, pediatric genetic

  • CNS: neurodegeneration, neuroinflammation, rare neurological diseases

  • Cardiometabolic: heart failure, NASH/MASH, obesity, lipid disorders

  • Infectious disease, immunology, and inflammation

  • Any other therapeutic area — scoped in initial consultation

Any disease. Any geography. Any funder.

OniX is not a rare disease-only service. We scout across all therapeutic areas — from oncology to CNS, from cardiometabolic to rare pediatric diseases. If there are researchers being funded for it anywhere in the world, we can find them. Our rare bone disease database is a case study in what this looks like — 44 researchers, 15 countries, 9 funding bodies, in one deliverable.

bottom of page